2 weeks after first injection

Not an expert, but seems pretty major to me. Hope he takes it all the way down and stays there.

ADT will really knock your PSA down most of the time. It sounds like the treatment is working, good luck with your treatments.

Regards,
Kris

That is very good news. He should talk to his doctor about any breast changes that bother him. Breast changes are a fairly common side effect and there are things his doctor can do to minimize them.

What type of "Hormone Treatment" is your husband being treated with? That's a dramatic result and improvement after only two weeks...And it's a very good sign..It means his cancer is VERY hormone dependent and the treatment is likely to be very effective.

He has had 3 injections in two weeks?

"about FIRMAGON

FIRMAGON is an injectable gonadotropin-releasing hormone (GnRH) receptor antagonist approved by the U.S. Food and Drug Administration (FDA) for the treatment of advanced prostate cancer. As a receptor antagonist, FIRMAGON reversibly binds to the GnRH receptors in the pituitary gland, immediately suppressing the secretion of the luteinizing hormone (LH), follicle-stimulating hormone (FSH), and subsequently, testosterone levels.1-4 FIRMAGON also reduces levels of prostate-specific antigen (PSA). Unlike luteinizing hormone-releasing hormone (LHRH) agonists, such as leuprolide, an established treatment for prostate cancer, FIRMAGON does not induce an initial testosterone surge. FIRMAGON is administered monthly by subcutaneous injection. The starting dose is 240 mg, followed by monthly maintenance doses of 80 mg. FIRMAGON is available for order through traditional and specialty pharmacy distributors. The average monthly cost of one year of FIRMAGON treatment is comparable to other hormone treatments for prostate cancer. The most commonly observed adverse reactions during FIRMAGON therapy included injection site reactions (e.g. pain, erythema, swelling or induration) and other androgen deprivation therapy (ADT) associated side effects including hot flashes, increased weight and fatigue. Ninety-nine percent of these observed adverse reactions were Grade 1 or 2 (mild to moderate). Specifically relating to the injection site adverse reactions, most were transient, of mild to moderate intensity, occurred primarily with the starting dose and led to few discontinuations (<1%). Grade 3 (severe) injection site reactions occurred in two percent or less of patients receiving FIRMAGON."

After just two weeks his PSA is just one-tenth of what it was before? Yes, that's a very good response!

That is good news and hope he gets a long way.